BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15710651)

  • 1. Private specificities of CD8 T cell responses control patterns of heterologous immunity.
    Kim SK; Cornberg M; Wang XZ; Chen HD; Selin LK; Welsh RM
    J Exp Med; 2005 Feb; 201(4):523-33. PubMed ID: 15710651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
    Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
    J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation.
    Kim SK; Brehm MA; Welsh RM; Selin LK
    J Immunol; 2002 Jul; 169(1):90-8. PubMed ID: 12077233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.
    Shen ZT; Nguyen TT; Daniels KA; Welsh RM; Stern LJ
    J Immunol; 2013 Nov; 191(10):5139-52. PubMed ID: 24127554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
    J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
    Selin LK; Vergilis K; Welsh RM; Nahill SR
    J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
    Che JW; Daniels KA; Selin LK; Welsh RM
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequencies of virus-specific CD8+ T-cell precursors.
    Seedhom MO; Jellison ER; Daniels KA; Welsh RM
    J Virol; 2009 Dec; 83(24):12907-16. PubMed ID: 19812167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.
    Liu F; Feuer R; Hassett DE; Whitton JL
    J Clin Invest; 2006 Feb; 116(2):465-75. PubMed ID: 16424939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.
    Nie S; Cornberg M; Selin LK
    J Immunol; 2009 Nov; 183(10):6554-60. PubMed ID: 19846867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.
    Selin LK; Varga SM; Wong IC; Welsh RM
    J Exp Med; 1998 Nov; 188(9):1705-15. PubMed ID: 9802982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.
    Masopust D; Murali-Krishna K; Ahmed R
    J Virol; 2007 Feb; 81(4):2002-11. PubMed ID: 17151096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of non-reciprocal heterologous immunity between unrelated viruses.
    Che JW; Selin LK; Welsh RM
    Virology; 2015 Aug; 482():89-97. PubMed ID: 25838115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.
    Brehm MA; Pinto AK; Daniels KA; Schneck JP; Welsh RM; Selin LK
    Nat Immunol; 2002 Jul; 3(7):627-34. PubMed ID: 12055626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
    Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
    Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD8+ T cells during subsequent viral infections.
    Dunbar E; Alatery A; Basta S
    Viral Immunol; 2007 Dec; 20(4):585-98. PubMed ID: 18158732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.